Athenex Inc

NASDAQ:ATNX   3:59:56 PM EDT
11.67
+0.22 (+1.92%)
Products, Strategic Combinations

Axis Therapeutics Announces Research Collaboration With Pharmaessentia For Development Of Tcr-T Cell Therapy In Taiwan

Published: 10/12/2020 20:11 GMT
Athenex Inc (ATNX) - Axis Therapeutics Announces Research Collaboration With Pharmaessentia for Development of Tcr-t Cell Therapy in Taiwan.
Athenex Inc - Under Terms, Axis Therapeutics,pharmaessentia to Collaborate to Conduct Initial Clinical Study of Axis Therapeutics' Tcrt-eso-a2 Therapy.
Athenex Inc - Pharmaessentia Will Be Responsible for All Activities Relating to Clinical Development in Taiwan.